FIELD: medicine.
SUBSTANCE: invention refers to medicine, particularly to endocrinology and surgery, and can be used for treating benign growths of the parathyroid gland. That is ensured by ultrasound-guided percutaneously injection into parathyroid adenoma area with 1 ml of 3% ethoxysclerol solution per 1 ml of parathyroid gland node volume. One month before the beginning of each course of sclerotherapy, alendronic acid is prescribed in tablets orally in dose of 70 mg once week for 28 days.
EFFECT: invention provides highly effective treatment of parathyroid adenoma.
1 cl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING DIFFUSE TOXIC GOITER | 2024 |
|
RU2828535C1 |
| METHOD AND MEANS OF LIPS OF MOUTH CORRECTION | 2023 |
|
RU2825521C1 |
| METHOD AND PREPARATION FOR TREATING BENIGN THYROID NEOPLASMS | 2005 |
|
RU2294195C1 |
| GEL FOR TREATING DIABETIC POLYNEUROPATHY OF LOWER EXTREMITIES | 2024 |
|
RU2829250C1 |
| METHOD OF TREATING HYPOTHYROIDISM WITH DALARGIN | 2023 |
|
RU2814749C1 |
| METHOD OF TREATING CHRONIC KIDNEY DISEASE WITH DALARGIN | 2023 |
|
RU2819638C1 |
| METHOD OF PRE-OPERATION DIAGNOSTICS OF PARATHYROID GLAND ADENOMA | 2013 |
|
RU2537213C1 |
| METHOD OF TREATING ENDOCRINE AUTOIMMUNE OPHTHALMOPATHY | 2024 |
|
RU2819981C1 |
| METHOD FOR PREOPERATIVE MARKING OF PATHOLOGICALLY CHANGED PARATHYROID GLANDS IN HYPERPARATHYROIDISM | 2024 |
|
RU2829683C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF MALIGNANT AND BENIGN PARATHYROID GLAND FORMATIONS IN PATIENTS WITH PRIMARY HYPERPARATHYROIDISM | 2020 |
|
RU2738305C1 |
